PSA Testing for Prostate Cancer: Latest Research Illuminates Risks, Benefits, and New Approaches
Recent renewed attention to prostate cancer and the PSA screening test, spurred by the diagnosis of former US President Joseph Biden, is once again igniting debate among health experts and patients worldwide — including in Thailand. Prostate cancer remains the most commonly diagnosed cancer among men in the United States and is a significant health concern for aging populations globally. The latest research and guidance show that the path forward for PSA (prostate-specific antigen) testing is both complicated and deeply personal, underscoring an urgent need for Thai men and their healthcare practitioners to weigh the pros and cons of screening within the context of current science and local realities.